NeuroCare Group is a healthcare organization specializing in mental health services, including depression treatment, neuromodulation, and personalized therapy. The company operates clinics and provides innovative treatment solutions for various neurological and psychiatric conditions.

NeuroCare Group

Flow Neuroscience develops a non-invasive brain stimulation technology called tDCS for the treatment of depression.

Flow Neuroscience

neurocare is innovating mental health and performance by personalizing therapy following a detailed assessment. neurocare’s objective, measurable and effective approach is based on our natural ability to learn (neuroplasticity) and technology to speed up the learning (neuromodulation).

neurocare helps individuals to improve their self regulation and hence is a sustainable solution. The neurocare group provides a Digital Therapy Platform and Teletherapy and our vertical integration and know-how in Science, Neuromodulation Technology and clinical SOP’s is unique.

neurocare group

Are you a practitioner considering taking the next step in your Psychiatry practice?

Experienced Psychiatrist & #TMS provider Dr Scott West, from our neurocare centers in Nashville will present a webinar on TMS in the treatment of Depression in an upcoming Webinar. 
 
In this Webinar we discuss:
🎓 History & Rationale for TMS in the treatment of Major Depressive Disorder
🧠 How TMS works and what are its affects on the brain
📰 Research on TMS until now
👨‍⚕️ Spectrum of treatments for MDD & TMS Compared (STAR*D Trial)
🙍‍♀️ Case Study of TMS in female patient with MDD
 
This is a great opportunity for any practitioner considering taking the next step and using Transcranial Magnetic Stimulation in their clinical practice.

Find the sign up link in the comments and register your interest today to be part of our live discussion!

#tms #rtms #depression #depressiontreatment #personalizedmedicine #psychiatry #neuromodulation #neurostimulation #neurotherapy #antidepressants #bestpractice

🙏 Today, we proudly recognize the incredible women who are helping to shape our company for the better. From spearheading groundbreaking research initiatives to leading regions and driving key departments within our organization, our women are catalysts for innovation, progress, and success every day.

🧠 🔬 They are the strategic minds shaping the future of healthcare, stewarding our finances, the creative forces behind our marketing and sales strategies, and the skilled developers building the technologies of tomorrow. They are the backbone of our clinics, providing compassionate care and delivering best-in-class treatments for mental health. They are the trainers who travel the world, empowering other medical practitioners to make a difference in patients' lives.

🌟 Our journey has been remarkable, and it's thanks to the relentless determination and dedication of these extraordinary women, many of whom have broken down barriers in their careers to inspire the next generation in business, engineering, neuroscience, and medicine.

Here's to the women of the neurocare group, trailblazers, leaders, and inspirations.

Happy International Women's Day! 💫

#iwd2024 #iwd2024womenleadingtheway #internationalwomensday2024 #internationalwomensday #womeninscience #womeninbusiness #womeninmedicine  #inspireinclusion 

neurocare's Dr. Trevor Brown, has just released a new episode in our podcast series, this time with Dr. Leo Chen who shares his expertise in #TMS Therapy and in particular, Theta Burst Stimulaton. 

A great episode of interest to anyone wanting to learn more about advanced #Depression treatments and further insights into Transcranial Magnetic Stimulation.

Dr. Leo Chen holds the roles of Senior Research Fellow in the Department of Psychiatry at Monash University, Head of the Brain Stimulation Lab, and Psycho-pharmacology Research Units at Monash Alfred Psychiatry Research Centre. 

Thank you Trevor and Dr. Chen, for sharing this information with us!

🔗 The link to the episode is in the comments and be sure to subscribe to our YouTube channel.

#tmstherapy #neuroscience #neuromodulation #depressiontreatment #innovationinhealth #mentalhealth #depressiontreatment #psychiatry #psychiatrist #neurostimulation #digitaltherapeutics


Good news for patients and our network of Apollo TMS providers in Florida. 
 
Florida Blue / Lucet, one of the largest insurance companies in the state of Florida, has announced changes in coverage policy for #TMS therapy for patients with #Depression. This change enables earlier access to TMS services for patients who have not been helped by antidepressant medication treatment. 

Previously, to be eligible for funding for TMS treatment, patients would have needed to undergo 4 unsuccessful medication treatments. However, this requirement has now been reduced to 2, and patients no longer need to have received psychotherapy treatment to access TMS.

Learn more about TMS, its benefits, and our network of Apollo TMS clinics in the United States: https://lnkd.in/eCJutZtT 
 
#TranscranialMagneticStimulation #rTMS #tmstherapy #neurostimulation #psychiatry  #depressiontreatment #mentalhealth #mentalhealthmatters  #healthcareinnovation #healthinsurance 

Metric
Company Name	NeuroCare Group	Flow Neuroscience
Symbol
MSH ID	COM:NEUROCAREGROUP	COM:FLOWNEUROSCIENCE
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare	Mental Health Services
Country	DE	GB
Stage
Employee Count	87
Website	neurocaregroup.com	flowneuroscience.com
LinkedIn	neurocaregroup
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		77.08K
Web Traffic Growth		-0.37
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:NEUROCAREGROUP

NeuroCare Group

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue